SCHEMBL7369905

SCHEMBL7369905

COc1ccc(OS(=O)(=O)C(F)(F)F)c(CCC(=O)O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.53
HSD17B10 Q99714 2/20 0.49
PPARG P37231 1/20 0.46
PPARD Q03181 1/20 0.46
PPARA Q07869 1/20 0.46
GAA P10253 1/20 0.43
KEAP1 Q14145 1/20 0.43
NFE2L2 Q16236 1/20 0.43
MAPT P10636 1/20 0.42
MTNR1A P48039 1/20 0.42
MTNR1B P49286 1/20 0.42
HTT P42858 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ADRA1A P35348 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
NPC1 O15118 1/20 0.41
PKM P14618 1/20 0.41
RAB9A P51151 1/20 0.41
FFAR1 O14842 1/20 0.41
FOS P01100 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7373033 0.87 HSD17B10 (0.41) POLBHSD17B10GAAMAPTMTNR1A
SCHEMBL21430976 0.84 GAA (0.47) HSD17B10GAAMAPTADRA1ATAAR1
SCHEMBL491188 0.82 HSD17B10 (0.71) POLBHSD17B10MTNR1AMTNR1BADRA1A
SCHEMBL30436820 0.82 HSD17B10 (0.71) POLBHSD17B10MTNR1AMTNR1BADRA1A
SCHEMBL21431072 0.79 GAA (0.45) HSD17B10GAAMAPTADRA1ATAAR1
SCHEMBL6720856 0.78 NPSR1 (0.48) KEAP1NPSR1FFAR1ALDH1A1
SCHEMBL7043778 0.78 MTNR1A (0.45) HSD17B10GAAMTNR1AMTNR1BHTT
SCHEMBL22946300 0.77 GAA (0.43) HSD17B10GAAMAPTADRA1ATAAR1
SCHEMBL903987 0.77 KDM4E (0.45) POLBMAPTNPC1RAB9AALDH1A1
SCHEMBL10909359 0.77 POLB (0.60) POLBHSD17B10PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1000031-A4 VITRONECTIN RECEPTOR ANTAGONIST SMITHKLINE BEECHAM CORP (US) 2001-08-16 EP disclosed
US-6239138-B1 TREATMENT OF INFLAMMATION, CANCER, CARDIOVASCULAR DISORDERS, SUCH AS ATHEROSCLEROSIS AND RESTENOSIS, OSTEOPOROSIS, BENZOCYCLOHEPTENYL IN WHICH A NITROGEN-CONTAINING SUBSTITUENT IS PRESENT ON THE AROMATIC SIX-MEMBERED RING AND AN ALIPHATIC SMITHKLINE BEECHAM CORPORATION 2001-05-29 US disclosed
EP-1000031-A1 VITRONECTIN RECEPTOR ANTAGONIST SmithKline Beecham Corporation (US) 2000-05-17 EP disclosed
WO-1999005107-A1 VITRONECTIN RECEPTOR ANTAGONIST SMITHKLINE BEECHAM CORPORATION (US) 1999-02-04 WO disclosed